评估认知脆弱的老年人数字健康干预措施的有效性和实施:系统性审查和元分析
Yanyan Li1, Meijun Liu2, Jieru Yang1
1Department of Basic Nursing, School of Nursing, Peking University, Beijing, China.
Ageing research reviews
|July 2, 2025
概括
数字健康干预显著改善认知功能,减少老年人的虚弱. 这些数字健康工具也提高了这群人的心理健康和身体生活质量.
科学领域:
- 老年学是一门学科.
- 数字健康数字健康
- 认知科学 认知科学
背景情况:
- 认知虚弱影响了老年成人人口的很大一部分.
- 数字健康干预为管理认知衰退和改善老年人的福祉提供了一个有希望的途径.
研究的目的:
- 系统地审查和评估对经历认知脆弱的老年人数字健康干预措施的有效性.
- 与对照组相比,评估这些干预措施的实施和影响.
主要方法:
- 进行了随机对照试验 (RCT) 和非随机干预研究 (NRSI) 的系统审查.
- 在十个电子数据库和灰色文献中进行了搜索,并于2025年3月进行了更新.
- 使用Cochrane RoB2和ROBINS-I工具进行了方法质量评估.
主要成果:
- 包括11个RCT和2个NRSI,涉及1069名参与者.
- 数字健康干预显著改善了全球认知功能 (SMD = 0.58) 和执行功能 (SMD = -0.54).
- 在生活质量 (PCS) 的身体领域 (SMD = 0.30) 也注意到改善,虚弱性 (SMD = -0.41) 和抑郁症状 (SMD = -0.41) 的减少.
结论:
- 数字健康干预措施在提高认知功能,心理健康和认知虚弱的老年人生活质量方面是有效的.
- 这些干预措施也在减少脆弱方面表现出有效性.
- 建议进一步进行高质量的研究,以加强现有证据基础.
更多相关视频
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.4K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.8K
相关概念视频
01:30Cognitive Development During Adulthood
299
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
299
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
213
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
213
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265